Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of peptides pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation. Founded in 2011, located in Harbin China. With registered capital 18.31 million, covering an area of 23,000㎡, construction area 16,000 ㎡. Our company has 260 employees, including 70 R&D personnel currently. Jixianglong has peptide drug production workshop and pilot workshop for neoantigen personalized tumor peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc. We are honored to be National High-tech Enterprise, Heilongjiang Province Small And Medium-Sized Sci-Tech Enterprise, Heilongjiang Province Innovation Center of Synthetic Peptide, Harbin Enterprise Technology Center and Heilongjiang Province Technology Innovation Demonstration Enterprise etc. Jixianglong has 10 APIs production approvals, Semaglutide and Tirzepatide have been filed in FDA USDMF and obtained the US National Drug Code (NDC). 16 invention patents achieved, including 5 compound patents.